Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$94,502,057
-$117,238,188 QoQ
Shares Held
678,066
-60.7% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 54.75646913427307.ToString("F0")%
Shared 0.ToString("F0")%
None 45.24353086572693.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2022CallValue
$422,095
CallShares
7,100
PutValue
$422,095
PutShares
7,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Man Group plc holds $1,645,149,077 across 10 Drug Manufacturers - General names. GILD ranks #6 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
422,016 | $388,157,656 | |
| 2 | ABBV |
AbbVie Inc.
|
1,774,415 | $385,917,516 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
5,658,497 | $343,187,842 | |
| 4 | AZN |
Astrazeneca PLC
|
628,476 | $123,948,035 | |
| 5 | MRK |
Merck & Co., Inc.
|
793,167 | $95,410,057 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
678,066 | $94,502,057 | |
| 7 | JNJ |
Johnson & Johnson
|
318,085 | $77,752,697 | |
| 8 | BIIB |
Biogen Inc.
|
318,745 | $58,435,520 |
All Filings in GILD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $94,502,057 | 678,066 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $211,740,245 | 1,725,112 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $194,981,601 | 1,756,591 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $174,615,259 | 1,574,955 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $186,517,084 | 1,664,588 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $80,655,542 | 873,179 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $52,786,669 | 629,612 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $81,624,698 | 1,189,691 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $72,614,482 | 991,324 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $37,211,861 | 459,349 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $42,902,999 | 572,498 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $85,438,028 | 1,108,577 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $122,968,508 | 1,482,084 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $197,359,704 | 2,298,890 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $102,091,025 | 1,654,904 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $89,670,423 | 1,450,743 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $59,303,157 | 997,530 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $422,095 | 7,100 | Call | Defined | 2022-05-16 | |
| 2022-03-31 | $422,095 | 7,100 | Put | Defined | 2022-05-16 | |
| 2021-12-31 | $48,041,316 | 661,635 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $26,768,475 | 383,228 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $36,802,708 | 534,457 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $80,942,481 | 1,252,398 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $71,211,837 | 1,222,311 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $76,745,328 | 1,214,517 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $79,840,637 | 1,037,700 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $43,153,415 | 577,226 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||